| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP2959894 | S1P Receptor Modulators For Treating Multiple Sclerosis | NOVARTIS AG | Dec 5, 2022 |
| EP1856051 | Amorphous Lercanidipine Hydrochloride | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. | Aug 4, 2020 |
Feel free to send us a message here and we will get back to you